Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,834.82
+26.851.49%
Number of Gainers:8
Number of Losers:11
Number of Flat:- -
PE:- -
High:1,846.22
Open:1,807.96
Low:1,807.96
Close:1,807.97
Volume:94.07M
Turnover:7.41B
Market Cap:1.49T
Float Cap:1.46T

Loading ...

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare

Dow Jones
·
Yesterday

AstraZeneca (AZN) Receives a Buy from Berenberg Bank

TIPRANKS
·
Yesterday

Pfizer (PFE) Receives a Hold from Berenberg Bank

TIPRANKS
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

BioNTech CEO Uğur Şahin Disposes of 93,000 Shares Worth $9,031,514.30

Reuters
·
Yesterday

Novavax Inc. Stock Slides 9.9%, Underperforms Peers

Dow Jones
·
Yesterday

Pfizer is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Yesterday

Inovio Adds Delaware Chancery Court Exclusive-Forum Bylaw for Key Shareholder Suits

Reuters
·
Yesterday

Scotts Miracle-Gro Names Prathima Hegde as CIO

Reuters
·
Yesterday

Equillium Posts New Preclinical EQ504 Data Supporting Ulcerative Colitis Potential at La Jolla Immunology Conference

Reuters
·
Yesterday

BridgeBio to Present New Real-World Study Comparing Acoramidis vs Pfizer’s Tafamidis in ATTR-CM at HFSA 2026

Reuters
·
Yesterday

Health Rounds: Experimental Approach May Eliminate Cold Storage Requirement for mRNA Vaccines

Reuters
·
Yesterday

Why Is Moderna Stock (MRNA) Falling Today, October 6?

TIPRANKS
·
Yesterday

Novavax Stock (NVAX) Plunges After WHO Calms Plague Fears

TIPRANKS
·
Yesterday

Vir Biotechnology EVP, CFO Aziz Sawaf Files Initial Beneficial Ownership Statement

Reuters
·
Yesterday

AstraZeneca price target raised to 18,600 GBp from 17,800 GBp at Citi

TIPRANKS
·
Yesterday

SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market

Reuters
·
Yesterday

Scotiabank Adjusts Pfizer Price Target to $33 From $30, Sector Outperform Rating Kept

MT Newswires Live
·
Yesterday